PBE Among Technology ETFs
End-of-day Nov 13, 2026 · 54 Technology ETFs by YTD
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.6% | −1.2% | −0.8% | +3.4% | +20.5% | +26.8% | +81.0% | +34.9% | +447.7% |
| Peer average | −1.2% | +2.0% | −7.3% | −10.1% | +6.1% | +4.9% | +72.6% | +26.1% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$57 of every $1,000 in PBE is Regeneron
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REGNRegeneron Pharmaceuticals | Healthcare | 5.66% | $565.87 | 26K | $25.0M |
| 2 | BIIBBiogen | Healthcare | 5.64% | $564.38 | 98K | $24.9M |
| 3 | GILDGilead Sciences | Healthcare | 5.61% | $560.95 | 146K | $24.8M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.55% | $554.56 | 350K | $24.5M |
| 5 | AMGNAmgen | Healthcare | 5.20% | $520.45 | 49K | $23.0M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 4.86% | $486.48 | 39K | $21.5M |
| 7 | NTRANatera | Healthcare | 4.67% | $467.02 | 64K | $20.6M |
| 8 | ILMNIllumina | Healthcare | 4.65% | $465.31 | 96K | $20.5M |
| 9 | MRNAModerna | Healthcare | 4.20% | $419.92 | 75K | $18.5M |
| 10 | VCELVericel | Healthcare | 3.69% | $368.89 | 274K | $16.3M |
| 11 | EXELExelixis | Healthcare | 3.34% | $334.29 | 209K | $14.8M |
| 12 | TGTXTG Therapeutics | Healthcare | 3.18% | $318.22 | 214K | $14.1M |
| 13 | QGENQiagen | Healthcare | 3.09% | $309.04 | 271K | $13.6M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.08% | $308.09 | 23K | $13.6M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 3.05% | $304.97 | 77K | $13.5M |
of the $365B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | 5.66% |
| 2 | BIIB | Biogen | 5.64% |
| 3 | GILD | Gilead Sciences | 5.61% |
| 4 | RPRX | Royalty Pharma | 5.55% |
| 5 | AMGN | Amgen | 5.20% |
| 6 | VRTX | Vertex Pharmaceuticals | 4.86% |
| 7 | NTRA | Natera | 4.67% |
| 8 | ILMN | Illumina | 4.65% |
| 9 | MRNA | Moderna | 4.20% |
| 10 | VCEL | Vericel | 3.69% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |